The Journal of Organic Chemistry · 2005 · 35 citations · 14 references
PharmacyBiochemistryMedicinal ChemistryDrug DesignDrug DiscoverySynthetic Medicinal ChemistryAmino Acid ChemistryPeptide ChemistryPeptide Drug DiscoveryPeptidomimetic DesignSolid-phase SynthesisBioactive Motif MimicsFmoc ChemistryPeptide Coupling ReagentsPeptide Medicinal ChemistrySolid-phase Organic SynthesisSolid-phase Peptide SynthesisSolid-phase Peptidomimetics
[structure: see text] A solid-phase fluorenylmethyloxycarbonyl (Fmoc)-based synthesis strategy is described for "mixed" aza-beta3-peptides as well as a convenient general approach for their required building blocks, the aza-beta3-amino acid residues (aza-beta3-aa). These monomers allow the synthesis of relatively large quantities of pure mixed aza-beta3-peptides. The required Fmoc-substituted aza-beta3-amino acids are accessible by convenient synthesis, and a number of monomers including those containing side chains with functional groups have been synthesized. The method was applied toward the solid-phase synthesis of aza-beta3-peptide mimetics of a biologically active histone H4 sequence.
14
Samuel H. Gellman · Accounts of Chemical Research · 1998 · 2.5K citations
Jack Sadowsky, Margaret A. Schmitt, Hee‐Seung Lee et al. · Journal of the American Chemical Society · 2005 · 166 citations